Aerpio Pharmaceuticals reported a net loss of $6.2 million, or $0.23 per share, in the fourth quarter of 2017 compared with a net loss of $4.6 million, or $4.76 per share, for the same period of 2016, according to a press release.
Operating expenses for the quarter increased from $3.3 million to $6.3 million.
For the full year, the company posted a net loss of $22.3 million, or $1.03 per share, compared with a net loss of $20.9 million, or $24.52 per share, in 2016.
Operating expenses for the year (Read more...)
Uncategorized